Prevalence of perennial severe allergic asthma in Italy and effectiveness of omalizumab in its management: PROXIMA – an observational, 2 phase, patient reported outcomes study

BACKGROUND: We designed the PROXIMA study (Patient-Reported Outcomes and Xolair(®) In the Management of Asthma) to determine the proportion of patients with severe asthma sensitive to perennial allergens, and to evaluate asthma control and treatment adherence up to 12 months in patients treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Canonica, Giorgio Walter, Bartezaghi, Marta, Marino, Raffaele, Rigoni, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494726/
https://www.ncbi.nlm.nih.gov/pubmed/26155196
http://dx.doi.org/10.1186/s12948-015-0019-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494726/
https://www.ncbi.nlm.nih.gov/pubmed/26155196
http://dx.doi.org/10.1186/s12948-015-0019-7

Ejemplares similares